sni neuro 2015 annual report

2015 Year in ReviewSutter Neuroscience Institute Providing High-Value, Personalized Care

4

Our MissionWe enhance the health and well-being of people in the communities we serve through a not-for-profit commitment to compassion and excellence in health services.

Our Vision Sutter Neuroscience Institute is the leading network of integrated, comprehensive neuroscience care in Northern California. Our nationally recognized team and partners together to deliver compassionate and personalized care, advance research and clinical outcomes while providing support to patients with complex neurological conditions.

At Sutter Health, we partner with you toward

a single goal: providing high-value, quality care

that’s more personalized and human.

When physicians and patients choose the Sutter

Neuroscience Institute, they are choosing a

comprehensive neuroscience program made up

of multidisciplinary teams of physicians, nurses,

technologists, therapists and administrators working

together to provide high-quality acute and outpatient

care, rehabilitation, and community education for

neuroscience services.

The 2015 Sutter Neuroscience Institute Year in Review

reflects the commitment of our teams to deliver

personalized patient care through collaboration,

innovation, safety, quality and excellence.

Patient CenteredClinical ExcellenceCompassion Collegiality

TeamworkIntegrity InnovationCommunity

Our Values

2015 Year In Review 1

2 A Note from the Valley Area Executive and Valley Area Medical Director

4 About the Sutter Neuroscience Institute

6 Sutter Neuroscience Leaders

7 Autism and Neurodevelopmental Disorders

7 Multiple Sclerosis

8 Epilepsy

10 Memory and Cognition

12 Parkinson’s Disease and Movement Disorders

13 Sleep Disorders

14 Spine and Neurosurgery

15 Brain Tumor Program

16 Stroke and Cerebrovascular Disorders

17 Interventional Neuroradiology

18 Trauma, Head Injury and Concussion

19 Sutter Rehabilitation Institute

20 Research and Clinical Trials

22 Community Events and Education

23 Philanthropy

24 Sutter Neuroscience Physicians

BC Contact Information and Locations

Sutter Health Valley Area Entities Memorial Hospital Los Banos Memorial Medical Center Sutter Amador Hospital Sutter Auburn Faith Hospital Sutter Center for Psychiatry Sutter Davis Hospital Sutter Gould Medical Foundation Sutter Medical Center, SacramentoSutter Roseville Medical CenterSutter Medical FoundationSutter Solano Medical CenterSutter Surgical Hospital North ValleySutter Tracy Community Hospital

TABLE OF CONTENTS

Sutter Neuroscience Institute2

A NOTE FROM THE VALLEY AREA EXECUTIVE AND VALLEY AREA MEDICAL DIRECTOR

Looking Back as We Expand into the Future

Elizabeth Mullikin, FACHE, FASETValley Area Neuroscience Service Line Executive

Gary Schneiderman, M.D.Valley Area Neuroscience Medical Director

2

To our community, colleagues and friends,

It’s an exciting time for Sutter Neuroscience Institute (SNI). We began another chapter in our unfolding story this year, when we extended our geographic reach deeper into the San Joaquin Valley. More important, we expanded our family of neuroscience professionals and brought easier access to advanced neurological care to more than a million Californians.

When we began this Institute in 1980, we were motivated by the knowledge that neurological conditions are often complex and that comprehensive care requires specialists from multiple disciplines. Establishing the Institute made it possible to collaborate and combine the best thinking of neuroscience experts to deliver the care patients need. It also allowed our physicians to work together on research, keeping us focused on finding ways to improve care.

Moving Beyond Sacramento

As Sutter Health grew, we expanded into the Greater Sacramento region, Sierra foothills and Solano County. Though we remained based in Sacramento, our physicians and services were no longer confined to one location. Patients gained better access to care, and the program benefitted from an influx of talent.

Expanding into the Valley

Now we’re reaching down the valley to include San Joaquin and Stanislaus Counties and Memorial Medical Center in Modesto, Tracy Community Hospital and Memorial Hospital in Los Banos. Once again, this expansion makes it easier for patients to receive advanced neurological care and the opportunity to participate in clinical trials, which would not otherwise be available to them. And the Institute adds new minds to help tackle the challenges neurological conditions present.

Growth on Several Fronts

As we expand into this larger geographical area, we’re continuing to advance new ideas in neurological condition causes and care. As they have in the past, our research efforts are garnering attention far beyond California. This year, one study in particular, published in the Journal of Neurology, Neurosurgery, and Psychiatry, captured the interest of Alzheimer’s disease researchers and others around the globe. Details about this encouraging study are included in the Memory Clinic section of this report.

Looking Ahead

We move forward into this new chapter knowing that it’s the journey to this point that makes new horizons possible. We thank the outstanding medical staff, employees, administration and volunteers that have made SNI a vital force in the neuroscience community and a strong ally in patient care. And we are grateful for your continued support that helps us bring about brighter futures for our patients.

With gratitude,

Advancing Neurosciences for Our Community 3

SNI Welcomes New Neuroscience Team Members in 2015

Neerali S. Bernard, D.O. Dr. Bernard is a board-certified neurologist with Sutter Medical Foundation’s neurology departments in Davis and

Sacramento. As a neurologist, Dr. Bernard specializes in general neurological disorders, including balance and gait, dementia, seizures, essential tremor, headaches and migraines, memory and aging, multiple sclerosis, Parkinson’s disease and stroke.

John K. Capua, D.O.Dr. Cupua is a neurosurgeon with Sutter Gould Medical Foundation’s neurosurgery department in Modesto. He

specializes in complex degenerative and minimally invasive spine surgery. Dr. Capua also treats adult complex degenerative spine, spinal cord tumors, spine trauma, spinal cord injuries, traumatic brain injury and minimally invasive spine surgery.

Myra Q. Hu, M.D.Dr. Hu is a board-certified neurologist with Sutter Medical Foundation’s neurology departments in Davis and

Sacramento. She treats a wide range of neurological conditions and has special interests in epilepsy, headaches and stroke care. Dr. Hu completed a fellowship in clinical neurophysiology, providing her with additional experience in electroencephalogram (EEG) interpretation, inpatient epilepsy monitoring, as well as performing and interpreting nerve studies and electromyograms (EMGs).

Amirth Jamoona, M.D. Dr. Jamoona is a board-certified neurosurgeon with Sutter Gould Medical Foundation’s neurosur-gery department in Modesto. Dr.

Jamoona’s fellowship specialized in cerebrovas-cular/endovascular neurosurgery. Dr. Jamoona treats brain tumors, brain aneurysms, brain malformations, pituitary tumors, herniated and slipped disks, spine fractures, degenerative dis-

ease of the neck and back, hydrocephalus, back and spine trauma. His surgical expertise includes neck and back surgery and fusion, stereotactic radiosurgery, surgery for hydrocephalus, carotid stenting and kyphoplasty/vertebroplasty.

Matthew Kimball, M.D.Dr. Kimball is a physician with Sutter Medical Foundation’s neurosurgery department in Roseville. His practice focuses

on a wide range of surgeries for conditions that include brain- and skull-based tumors, spinal degeneration, spinal tumors, peripheral nerve disorders, neuropathy, and trauma. He is experienced in radiosurgery and spinal revision techniques.

Eniko E. Nagy-Wilde, M.D. Dr. Nagy-Wilde is a board-certified neurologist with Sutter Medical Foundation’s Neurology Department in Sacramento. She

treats a wide range of neurological conditions and has a special interest in epilepsy and Intraoperative Monitoring, with additional experience in electroencephalogram (EEG) interpretation, inpatient epilepsy monitoring, invasive EEG (Phase II) monitoring, epilepsy surgery, electrocorticography, language mapping and Intraoperative Monitoring.

Deepak Sreedharan, M.D. Dr. Sreedharan is a board-certified pain management specialist with Sutter Medical Foundation’s neurology

departments in Davis and Fairfield. Dr. Sreedharan is an interventional spine specialist but also treats nerve entrapment syndromes, complex regional pain syndrome and headaches using the latest interventional techniques under both fluoroscopy and ultrasound guidance.

Kevin Bixel, PA-C, Neurological Surgery

Yolo

Yuba Placer

Amador

SacramentoSolano

San Joaquin

Stanislaus

Tracy

Stockton

Modesto

Jackson

Sacramento

Roseville

Auburn

Vallejo

Davis

Yuba City

■■ Pain Management■■ Neurodiagnostics ■■ Neurology■■ Sleep Medicine■■ Spine Surgery

■■ Neurodiagnostics■■ Neurology ■■ Pain Management■■ Sleep Medicine■■ Spine Surgery ■■ Stroke Center (Primary)

Fairfield/Vacaville

■■ Neurodiagnostics■■ Neurology ■■ Pain Management■■ Spine Surgery■■ Stroke Center (Primary)

■■ Neurodiagnostics ■■ Neurology ■■ Pain Management■■ Sleep Medicine■■ Stroke Center (Primary)

■■ Neurodiagnostics■■ Neurology■■ Pain Management■■ Spine Surgery

Sutter Health Hospital and Outpatient Facility

Outpatient Facility

■■ Neurology■■ Pain Management■■ Sleep Medicine

Neuroscience Service Area Map


SUTTER NEUROSCIENCE INSTITUTE 2015 AT A GLANCE

Counties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12

Estimated population . . .4.6 Million

Acute Care Facilities . . . . . . . . . . . . . . 11

Outpatient Visits . . . . . . . . . . . . . . .69,955

• Neurosurgery . . . . . . . . . . . . . . .10,358

• Spine Surgery . . . . . . . . . . . . . . . 4,670

• Neurology . . . . . . . . . . . . . . . . . . .36,789

• Pediatric Neurology . . . . . . .10,900

• Physical Medicine/ Rehabilitation . . . . . . . . . . . . . . . . . . .856

• Pain Management . . . . . . . . . . 5,909

• Psychology . . . . . . . . . . . . . . . . . . . . .473

Inpatients Visits . . . . . . . . . . . . . . . . . 7,344

• Neurology . . . . . . . . . . . . . . . . . . . . 3,945

• Neurosurgery . . . . . . . . . . . . . . . . . . .633

• Spine . . . . . . . . . . . . . . . . . . . . . . . . . . 2,250

• Stroke . . . . . . . . . . . . . . . . . . . . . . . . . 2,226

• Trauma . . . . . . . . . . . . . . . . . . . . . . . . . . .516

Placer

■■ Epilepsy Monitoring (Adult/Peds)■■ Gamma Knife Radiosurgery■■ Interventional Neuroadiology■■ Neurology (Adult/Peds)■■ Neurosurgery (Adult/Peds)■■ Neurodiagnostics (Adult/Peds)■■ Neuro-Intensive Care■■ Neuro-Oncology■■ Neuro-Psychology (Adult/Peds)■■ Pain Management■■ Sleep Disorders Center (Adults/Peds)■■ Spine Surgery (Adult/Peds)■■ Stroke Center (Primary)

■■ Interventional Neuroadiology■■ Neurodiagnostics ■■ Neurology (Adult/Peds)■■ Neurosurgery ■■ Neuro-Intensive Care■■ Neuro-Rehab (Acute)■■ Pain Management■■ Sleep Disorders Center (Adult/Peds)■■ Spine Surgery ■■ Stroke Center (Primary)■■ Trauma Services

■■ Neurodiagnostics ■■ Neurology (Adult/Peds)■■ Neurosurgery ■■ Neuro-Intensive Care ■■ Neuro-Oncology■■ Pain Management■■ Sleep Disorders Center ■■ Spine Surgery ■■ Stroke Center (Primary) ■■ Trauma

■■ Neurodiagnostics ■■ Neurology■■ Pain Management■■ Sleep Disorders Center ■■ Stroke Center (Primary)

■■ Neurology■■ Pain Management■■ Sleep Medicine

Sutter Neuroscience Institute at a Glance


Sutter Tracy Community Hospital and Sutter Medical Center, Sacramento were named two of the nation’s 100 Top Hospitals® by Truven Analytics™

Sutter Medical Center, Sacramento is a Level 4 Center by the National Association of Epilepsy Centers

The Joint Commission recognition as “Primary Stroke Center” Memorial Medical Center, ModestoSutter Amador HospitalSutter Auburn Faith HospitalSutter Davis Hospital Sutter Medical Center, SacramentoSutter Roseville Medical CenterSutter Solano Medical Center

Sutter Medical Center, Sacramento received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award.

Sutter Solano Medical Center Top Performer for Stroke Care by The Joint Commission (based on 2014 ORYX data)

Sutter Medical Foundation received California Association of Physician Groups “Elite” status

Sutter Auburn Faith Hospital recognized by Healthgrades for clinical excellence in Treatment of Stroke

The Neurodiagnostic Laboratory at Sutter Medical Center, Sacramento and Sutter Roseville Medical Center are accredited by the American Board of Registered Electroencephalographic Technologist as an ABRET-accredited neurodiagnostic lab.

Sutter Rehabilitation Institute is a Comprehensive Inpatient Rehabilitation Accredited by The Commission on Accreditation of Rehabilitation Facilities in Stroke Rehabilitation (adults) and Brain Injury Rehabilitation (adults and adolescents)

Medical Directors


Tyler Smith, M.D. Valley Area

Spine Surgery Program Medical Director

2015 SUTTER NEUROSCIENCE INSTITUTE

Richard Atkinson, M.D.Stroke & Vascular Neurology

Medical Director

Shubhangi Chitnis, M.D.Sutter Medical Center, Sacramento

Pediatric Neurology Medical Director

Samuel Ciricillo, M.D., FACS Adult and Pediatric Neurosurgery

Medical Director

William Au, M.D. Adult & Neuroscience Outpatient

Clinical Medical Director and Memory Co-Medical Director

Shawn Kile, M.D. Clinical Innovation & Research Medical Director and Memory

Co-Medical Director

Bradley E. Chipps, M.D. Pediatric Sleep Program

Medical Director

Robert G. Monie, M.D. Sutter Amador Sleep

Disorder Center Medical Director

Lydia Wytrzes, M.D. Sleep Disorders Centers

Medical Director

Gary Schneiderman, M.D. Valley Area Medical Director

Dr. Adora Matthews Sutter Rehabilitation Institute

Medical Director


Autism and Neurodevelopmental DisordersAt the Autism Medical Treatment Center, we provide care for patients with autism spectrum disorder (ASD)—including autistic disorder, Asperger syndrome and pervasive developmental disorder-not otherwise specified—and support for their families. From diagnosis in childhood throughout patients’ lives, our pediatric and adult neurologists, neuropsychologists, pediatric and adult rehabilitation therapists, and social workers provide ongoing medical care to patients and assist primary caregivers in maximizing quality of life for patients and families.

Active in research, our team is continually striving to learn more about the aging process in developmental disorders and finding

More than

3.5 Million Americans live with an autism spectrum disorder. (Buescher et al., 2014)

Each year in the U.S., approximately

50,000 Children with autism become adults. (Shattuck, et al., 2012)

new ways to diagnose and treat these conditions through adulthood. Please see the research section list of studies for the latest research related to autism spectrum disorders.

Our center is one of the few places that integrates diagnosis and treatment of ASD-related medical issues. We also offer young to middle-age adults with autism access to our Sutter Transition for Autism and Neurodevelopmental Disorders (STAND) Clinic to help patients and caregivers manage neurodevelopmental medical issues. At the STAND Clinic, we focus on medical care while also addressing the emotional and psychological challenges our adult patients and their caregivers face.

Diagnosing multiple sclerosis is often challenging. Symptoms may be vague and often mimic other conditions. At Sutter Neuroscience Institute, we offer the comprehensive testing and the diagnostic skill of a neurologist recognized as a Partner in MS Care by the National Multiple Sclerosis Society.

Following diagnosis, we work closely with our patients to develop a long-term treatment strategy and ensure they receive care for comorbidities that often develop. When patients

Multiple Sclerosisrequire additional assistance to manage comorbidities, we draw on our team of allied specialists, which includes ophthalmologists, urologists, neuropsychologists, physical therapists and others. This approach provides patients access to the care they need, coordinated by their neurologist. With a team of experts that includes the patient and family, we work together to help our patients live full and productive lives.


Laser Ablation Cases 18Inpatient EEG Volume 2,241Outpatient EEG Volume 2,565

At Sutter’s Comprehensive Epilepsy Program, our goal is to provide effective, extensive treatment options in a safe and nurturing environment that supports each patient’s physical and emotional well-being.

Our multidisciplinary epilepsy team provides top-level, comprehensive diagnosis and treatment services for patients suffering from seizures. Sophisticated testing and brain-mapping capabilities enable us to identify the seizure type and

Epilepsy source within the brain. Following diagnosis, we offer a full range of treatment options, including medication management, surgery, innovative laser ablation surgery and more.

Each patient’s experience of epilepsy is unique. By working to provide precise diagnosis and highly personalized care, we strive to ensure that treatment strategies chosen offer the most-effective and best-tolerated approach for every patient and family we serve.

ABRET accreditation awards neurodiagnostic laboratories that demonstrate adherence to the highest standards of EEG placement, technical quality and continuous improvement.

• Treatment Medication therapyImage-guided laser tissue ablation surgeryNeurosurgery Corpus callosotomyHemispherectomyVagus nerve stimulationTemporal lobectomyKetogenic diet

• Clinical Trials

Services Offered

• Consultation

• Comprehensive neurological examination

• Diagnostic testing EEG monitoring Evoked Potentials: Visual Evoked Potential (VEP), Brainstem Auditory Evoked Potential (BAEP) and Somatosensory Evoked Potential (SSEP)Hospital-based 24-hour adult and pediatric monitoring unitNeuro-imaging including MRI studies, CT, PET, brain spectroscopy, angiography and WADA testingNeuropsychological evaluation Genetic testing

Sagittal MRI showing Stereotactic Laser Ablation of seizure onset zones

Laser Ablation Surgery for Epilepsy and Brain Tumors

For the one-third of patients whose epilepsy is not controlled by medication, surgery has offered hope. In recent years, our epilepsy team has helped pioneer an innovative minimally invasive surgery that is proving to be an effective alternative to open surgery for many patients.

MRI-guided laser ablation uses carefully administered light and heat to destroy brain issue from which seizure-causing electrical activity erupts. The procedure requires surgeons to drill a hole about the size of a coffee stirrer in the skull. Using MRI guidance, the surgeon inserts a thin laser probe through the hole and into the identified tissue. After confirming the location, the laser heats the tissue enough to destroy it with minimal damage to surrounding tissue.


Following surgery, patients typically stay one night in the hospital and go home the next day.

Laser ablation surgery is also being used to treat brain tumors, for patients with inoperable tumors.

Sutter Neuroscience Institute neurosurgeon Samuel Ciricillo, M.D., FACS, received the Flame Award from the Epilepsy Foundation of Northern California at the annual EFNC Gala for Care and Cure in November 2015. The flame is the symbol of epilepsy throughout the world; it stands for bringing light to epilepsy and for being a patient advocate. Dr. Ciricillo received the award in part for his contribution to the minimally invasive laser ablation procedure that he, Dr. Michael Chez and neuroradiologist Dr. Azad Ghassemi helped to develop.

3 Million Number of people in the United States who have epilepsy.

1 in 26 people in the United States will develop epilepsy at some point in their lifetime.

150,000 Number of new cases of epilepsy in the United States each year Source: Epilepsy Foundation

Like Us on Facebook Sutter Pediatric Epilepsy

10

Memory and Cognition Researchers estimate that 1 in 9 percent of Americans age 65 and older are struggling with some form of dementia. With the number of Americans reaching age 65 expected to more than double by 2060, there’s added urgency to understanding the causes and finding cures for vascular dementia, Alzheimer’s disease, and other conditions that impair memory and cognition.

At the Sutter Neuroscience Institute, we’re helping to advance the science through care and research.

Memory Clinic For patients and families facing memory challenges today, our Memory Clinic offers personalized, comprehensive diagnosis and care. Our expert team of neurologists, neuropsychologists, cognitive test professionals and social workers works together with patients and families to evaluate where a patient is today, provide medical care and develop long-term care strategies.

Areas of focus include:• Psychometric testing• Preserving memory function• Healthy aging education• Individualized care plans• Referrals as needed, including

neuro-psychologyOur team also collaborates with community services, such as Alzheimer’s organizations, support groups, and a number of adult care facilities, including Sutter SeniorCare.

Approximately

5.4 Million Americans have Alzheimer’s disease, including one in nine Americans over age 65. Source: Alzheimer’s Association

Approximately

1 in 9 age 65 and older has Alzheimer’s Disease. Source: Alzheimer’s Association

35.6 Million people worldwide were estimated to be living with dementia in 2010, a number expected to reach 115.4 million people by 2050. Prince, et al., 2013

Sutter Neuroscience Memory Clinic is at the forefront in establishing early diagnosis and intervention to preserve cognitive function and possibly delay the onset of dementia.

Research We’re also actively involved in research in the field of memory and cognition. Through our connection with Sutter Institute for Medical Research (SIMR), our physicians routinely serve as primary investigators on clinical trials. Members of our team have also proposed and conducted studies through SIMR, including a study published in 2015 and highlighted on these pages investigating the effects of intravenous immunoglobulin on patients in the earliest stages of Alzheimer’s disease. A list of additional studies underway during 2015 is included at the end of this report.

Sutter Neuroscience Institute

Sutter Memory Clinic Study Shows IVIG Could Be Key to Alzheimer’s Cure

In September 2015, the Journal of Neurology, Neurosurgery, and Psychiatry published a Sutter Institute of Medical Research (SIMR) research study showing the blood product intravenous immunoglobulin, or IVIG, reduced brain atrophy and cognitive decline in patients in the early, pre-dementia phase of Alzheimer’s disease.

Shawn Kile, M.D., co-medical director of the Sutter Memory Clinic and Sutter Medical Foundation neurologist, was the principal investigator of the double-blinded study, which was designed through a collaboration between SIMR, Sutter

Neuroscience Institute and Sutter Neuroradiology. William Au, M.D., a renowned neurologist and expert in the treatment of Alzheimer’s disease who recently retired as co-director of the Sutter Memory Clinic, served as an investigator on the study. Sutter Medical Foundation neuroradiologist Azad Ghassemi, M.D., also served as an investigator.

Dr. Ghassemi conducted brain imaging studies at baseline and at 12 and 24 months following IVIG treatment. At 12 months, images for those who received the IVIG doses showed less brain atrophy than those who were given the placebo.

In addition, cognitive testing showed better results and there were fewer conversions to dementia after 12 months for those who received IVIG. Differences in the treatment versus placebo groups faded by 24 months. Dr. Kile and colleagues propose that annual infusions of IVIG may be necessary to sustain treatment effects, but additional research will be necessary to prove this.

Dr. Kile said about the study, “My hope is that our study will lead to additional investigations of this treatment strategy so we can eventually conquer this devastating disease.”



Needle electromyography (EMG) samples a specific muscle to determine if it is diseased.

Sutter Neuroscience EMG Lab Electromyogram (EMG) & Nerve Conduction StudiesOur in-house EMG labs in Sacramento & Davis, provide electromyogram and nerve conduction testing to diagnose a wide variety of peripheral nerve and muscle disorders including: neuropathies (disorders of the nerves), radiculopathies (pinched nerves in the neck or lower back) and myopathies (disorders of the muscles).

Electromyogram studies measure the electrical activity present in muscles at rest and during contraction. Nerve conduction studies show how well the nerves work. Like electrical wires, the nerves conduct electrical signals. During nerve conduction testing, the nerves are stimulated at one end and a recording of the response is made at the other end.

At Sutter Neuroscience Institute, our nationally recognized team of medical experts helps improve the quality of life for patients with Parkinson’s disease, essential tremor, dystonia, Huntington’s disease, restless leg syndrome and other gait, tremor and movement disorders.

Parkinson’s Disease and Movement Disorders

According to the American Academy of Neurology, up to

10 Percent of Americans live with some form of movement disorder.

Using a wide range of techniques and technology—which may include comprehensive consultations, neurodiagnostic imaging, laboratory analysis, genetic testing, specialized nerve testing and video analysis—our specialists diagnose conditions and formulate treatment plans.


Home Sleep Studies 509Sleep Procedures Volume 3920

1 out of 4

individuals have sleep

disorders

Our in-home sleep testing program allows patients to undergo testing in the comfort of their own homes.

Sleep DisordersEstablished in 1984, the Sutter Sleep Disorders Center has helped thousands of children and adults discover the causes of and solutions to sleep-related problems. As part of the Sutter Neuroscience Institute, the center offers patients access to the latest sleep testing equipment and advanced treatment for conditions that include sleep apnea, snoring, insomnia, restless leg syndrome, narcolepsy and other conditions that interrupt or prevent restful sleep.

Our team of sleep experts includes board-certified physicians in adult and pediatric sleep medicine, neurologists, pulmonologists, registered polysomnographic technologists, respiratory care practitioners and support staff. With offices conveniently located throughout our expanded geographical region, The Joint Commission-certified Sutter Sleep Disorder Center facilities located in Sacramento, Roseville, Modesto and Jackson offer daytime nap and overnight testing monitored by polysomnographic technologists.

In addition to testing in our sleep center facilities, we began offering home-based sleep testing in 2014. The innovative approach allows patients to receive test equipment and instructions by mail and conduct sleep tests in the comfort of their own beds. Interest in home-based sleep testing grew in 2015 and we anticipate further growth as more people learn about this convenient and comfortable sleep-testing option.

Testing Offered

• Nighttime testing

Polysomnogram

Continuous positive airway pressure (CPAP) titration

Split-night polysomnogram/CPAP

Bi-Level Positive Airway Pressure and Variable Positive Airway Pressure

• Daytime testing

Mean sleep latency test (MSLT)

Maintenance of wakefulness tests (MWT)

• Home (nighttime) testing

Unattended polysomnogram

Depending on the diagnosis, treatments may include medication, botulinum neurotoxin injections or deep brain stimulation surgery. In addition to caring for patients directly, we assist primary care providers with movement disorder diagnoses, provide second opinions and act as a resource.


As surgery moves away from open procedures, we are actively forwarding the shift to minimally invasive and noninvasive procedures where possible. Our work with gamma knife, laser ablation, neuroendoscopy, microdiscectomy, neurointerventional radiology and other less-invasive procedures offers excellent treatment options for many children and adults.

However, many conditions of the brain, spine and nervous system are best addressed through traditional surgery. When this is the case, our patients have access to excellent surgical facilities and hospitals, skilled and caring neurosurgery and orthopedic spine surgery specialists, nurses, physical therapists and others who come together to provide personalized care from diagnosis through recovery.

Spine and Neurosurgery

Treatment options for adults include:

• Cranial base surgery

• Craniotomy

• Deep brain stimulation

• Disc and spinal cord decompression

• Dorsal column stimulation

• Gamma Knife Stereotactic Radiosurgery

• Laminectomy

• Laser Ablation Surgery

• Microvascular decompression

• Minimally invasive spine surgery

• Neuroendoscopy

• Spinal fusion

• Spinal reconstruction

• Transsphenoidal surgery

• Tumor resection

• Ventriculo-peritoneal shunting

• Vagus nerve stimulation

• Vertebroplasty

Treatment options

Valley Area Spine Advisory and New Technology Committee

We established our committee to promote outcomes excellence for spine patients. The committee provides high-level and rigorous examination in selecting new spine technology, including medical devices.

The committee is designed to address the rapid advance of medical technology by providing a forum to review product information and view results of clinical trials and other data on recently introduced spine technology. The committee also reviews spine care dashboards and quality metrics to solidify the Sutter Neuroscience Institute goal of constantly evolving toward ever-higher standards of care.

for children include:

• Baclofen pump insertion

• Cervical fusion

• Chiari decompression

• Craniotomy

• Epilepsy surgery

• Gamma Knife Stereotactic Radiosurgery

• Laser Ablation Surgery

• Minimally invasive spine surgery

• Myelomeningocele closure

• Neuroendoscopy

• Scoliosis correction

• Synostectomy

• Tethered cord surgery

• Transsphenoidal surgery

• Tumor resection

• Ventriculo-peritoneal shunting

Total Spine Cases 1915Total Neurosurgery Cases 919


Our Brain Tumor Program provides patients of all ages with diagnosis and care for benign and malignant brain tumors and tumors involving the spinal cord.

As with other institute programs, the Brain Tumor Program combines the expertise of specialists from several disciplines, including neuro-oncologists, neurosurgeons, radiation oncologists, neuroradiologists, pathologists, neuro-psychologists and nurses. In addition to providing care, the team meets twice each month to discuss patients’ diagnoses, treatments options, opportunities to enroll in clinical trials and other ways to ensure each patient receives the best care possible. Through this approach, each patient receives a personal, comprehensive treatment plan monitored by the team.

Brain Tumor ProgramMedical treatment may include traditional and minimally invasive surgery, including leading-edge laser ablation and neurointerventional radiology treatments. We are also offer the latest equipment to perform noninvasive gamma knife radiosurgery.

Beyond medical treatment, we take time for the human side of care—mak-ing a compassionate connection with each patient and family, learning about each patient’s goals for the future, and helping patients and families connect with support services that help to make a difficult time less stressful.

Gamma Knife Radiosurgery Center After more than 15 years of offering Gamma Knife Radiosurgery, Sutter Neuroscience Institute has invested in the latest Gamma Knife technology. This technology allows our team to deliver the most precise radiosurgery, limiting radiation exposure to healthy tissue. The new technology offers a “frameless” approach, with the same accuracy of framed-based systems. The Icon also provides the flexibility for single dose administration or multiple treatment sessions over time, which enables treatment of larger tumor volumes, targets close to critical brain structures and new or recurring brain metastases.


Interventional NeuroradiologySutter Neuroscience Institute interventional neuroradiologists work in collaboration with neurologists and neurosurgeons to provide treatment of cerebrovascular diseases in patients suited for this minimally invasive approach.

Working from within blood vessels, interventional neuroradiologists are able to treat many aneurysms, ischemic stroke blood clots, arteriovenous malformations, and tumors of the brain, spine, head and neck—without the need for surgery. This rapidly advancing treatment approach requires the highly specialized surgical expertise and sophisticated imaging and medical equipment available through the Institute.

Conditions & Procedures • Biopsies

Full-service percutaneous image-guided biopsies

Spinal column

Head and neck

• Cerebrovascular

Arteriovenous fistula embolization – brain, head, neck and spine

Arteriovenous malformation embolization – brain, head, neck and spine

Carotid artery stenting

Carotid artery angiogram

Cerebral aneurysm embolization

Cerebral angiogram

Intracranial artery stenting for stroke reduction

Intracranial stenting and angioplasty

Intracranial thrombectomy for treatment of stroke

• Endocrine

Parathyroid hormone sampling

Petrosal venous sampling

Sclerotherapy for lymphatic and venous malformations

• Spine

Spinal arteriovenous malformation embolization

Vertebral artery stenting

Kyphoplasty

Sacroplasty

Vertebroplasty

2015 Year In Review


Our commitment to timely, evidence-based care of stroke patients has earned seven of our acute care hospitals the Joint Commission’s Gold Seal of Approval® as Primary Stroke Centers.

Stroke Measure DescriptionNational Average

Valley Area*

Venous Thromboembolism (VTE) Prophylaxis

Ischemic or hemorrhagic stroke patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given on the day of or the day after hospital admission

96% 98.9% (1312/1326)

Discharged on Antithrombotic Therapy Ischemic stroke patients prescribed antithrombotic therapy at hospital discharge

99% 99.7% (1134/1137)

Anticoagulation Therapy for Atrial Fibrillation/Flutter

Ischemic stroke patients prescribed anticoagulation therapy at hospital discharge

96% 95.5% (171/179)

Thrombolytic Therapy Acute ischemic stroke patients for whom IV thrombolytic therapy was initiated at this hospital within 3 hours (< 180 minutes) of time last known well

76% 94.6% (105/111)

Antithrombotic Therapy By End of Hospital Day 2

Ischemic stroke patients who had antithrombotic therapy administered by end of hospital day 2

98% 99.6% (984/988)

Discharged on Statin Medication Ischemic stroke patients prescribed statin medication at hospital discharge

96% 98.3% (882/897)

Stroke Education Patients with documentation that they or their caregivers were given educational material addressing all of the following:

1. Activation of emergency medical system 2. Need for follow-up after discharge 3. Medications prescribed at discharge 4. Risk factors for stroke 5. Warning signs for stroke

92% 95.3% (690/724)

Assessed for Rehabilitation

Percent of patients with stroke who were assessed for rehabilitation services

98% 99.6% (1301/1305)

At Sutter Neuroscience Institute, we demonstrate the highest level of commitment to caring for stroke patients and those at risk of cerebrovascular accidents. We provide emergency care for stroke through our seven Joint Commission-designated Primary Stroke Centers and through consultation with medical staff at other Sutter Health

Stroke and Cerebrovascular Care

*CY2015: Memorial Hospital, Los Banos (MHLB), Memorial Medical Center (MMC), Sutter Amador Hospital (SAH), Sutter Auburn Faith Hospital (SAFH), Sutter Davis Hospital (SDH), Sutter Medical Center, Sacramento (SMCS), Sutter Roseville Medical Center (SRMC), Sutter Solano Medical Center (SSMC), Sutter Tracy Community Hospital (STCH)

hospital emergency departments. For patients at risk of stroke, we offer preventive therapies, including lifestyle modifications, medications and surgical treatments. Our experts also provide expert guidance for patients undergoing rehabilitation following a stroke, including preventive therapies to reduce the risk of another stroke.

ISCHEMIC

Volume 1559

Discharged Home 83.8%HEMORRHAGIC

Volume 250 Discharged Home 72.6%


Trauma, Head Injury and Concussion Sutter Roseville Medical Center and Memorial Medical Center are accredited by the American College of Surgeons as Level II Trauma Centers for services that include neurological trauma care. Care of each patient is managed directly by a trauma surgeon, on site 24 hours a day, who acts as the single reference point for all information and decisions.

Neurosurgical services to the trauma program include specialty support for traumatic brain and spinal cord injuries.

In addition to our trauma center, the Sutter Neuroscience Institute has partnered with healthcare organizations in the Sacramento area to offer a Concussion Clinic that provides ImPACT credentialed consultants. The clinic provides computerized neurocognitive assessment tools and services that are used by medical doctors, psychologists, athletic trainers, and other licensed healthcare professionals to assist in determining an athlete’s ability to return to play after suffering a concussion.

Concussion Volume Adults 1277Concussion Volume Children & Teens 621

Stroke 312

Brain Injury 107

Spinal Cord Injury 62Data from UDSmr® and iTHealthTrack Inc.

Sutter Rehabilitation InstituteAt 55,000 square feet and with 55 beds, the Sutter Rehabilitation Institute (SRI) at Sutter Roseville Medical Center is a regional inpatient acute rehabilitation center designed for patients who have been disabled by illness or injury. Utilizing a 3,000-square-foot therapy gym and the only specialized brain injury unit in the region, SRI provides specialty rehabilitation programs for people recovering from stroke, brain injury and spinal cord injury. The goal is to maximize the abilities of patients to achieve their maximum functional independence and foster a healthy reintegration into the community.

Our program exceeds discharge to the community expectations and surpasses other rehabilitation facilities in the United States.

Brain Injury Rehabilitation (adults and adolescents)


After a traumatic brain injury Andy was told her life as an athlete had ended, but her positive attitude and specialized rehabilitation program put her back in the competition.

Andy Athlete, Mother, Brain Injury Survivor


Research and Clinical Trials At Sutter Neuroscience Institute, we are fortunate to work with physicians willing to take time out of their already busy schedules to serve as research investigators. Research in a community patient care setting advances medical knowledge in a unique way, while also providing our patients access to clinical trials of new treatments that show promise.

Clinical Trial Principal Investigator(s)

A Randomized Double-Blinded Placebo-Controlled Exploratory Study of Intravenous Immunoglobulin (New Gam 10%) in Amnestic Mild Cognitive Impairment

Patients with mild cognitive impairment (MCI) are a group recognized at being at high risk of progressing to Alzheimer’s disease. Treatment of MCI with immunotherapy with intravenous immunoglobulins (IVIG) could potentially reduce the risk of progression to Alzheimer’s disease. This study will evaluate the efficacy of intravenous immunoglobulin in patients with MCI over 24 months after the first infusion. This study will also document conversion from MCI to Alzheimer’s disease.

Shawn Kile, M.D.

William Au, M.D.

A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer’s Disease.

This study will assess the safety, tolerability, and efficacy of two doses of MK-8931 on cognition and functional ability in activities of daily living in subjects with mild to moderate AD.

Shawn Kile, M.D.

William Au, M.D.

A Phase III, Randomized, Placebo Controlled, Parallel-Group, DoubleBlind Clinical Trial to Study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease (Prodromal AD)

The purpose of this trial is to assess the efficacy and safety of MK-8931 compared with placebo in the treatment of amnestic mild cognitive impairment (aMCI) due to Alzheimer’s disease (AD), also known as prodromal AD. Participants will be randomized to receive placebo, or 12 mg or 40 mg MK-8931, once daily. The primary study hypothesis is that at least one MK-8931 dose is superior to placebo with respect to the change from baseline in the Clinical Dementia Rating scale-Sum of Boxes (CDR-SB) score at 104 weeks.

Shawn Kile, M.D.

William Au, M.D.


Clinical Trial Principal Investigator(s)

Streptococcal Antibodies in Autism Spectrum Disorders with Catatonia

Collecting data in patients with neurodevelopmental disorders presenting with a PANDAS-like syndrome.

Shawn Kile, M.D.

Michael Chez, M.D.

A Phase III Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme

This Phase III trial is designed to evaluate the impact on disease progression and survival time, as well as safety, in patients following treatment with DCVax(R)-L, an immunotherapy treatment for GBM. The experimental therapy uses a patient’s own tumor lysate and white blood cells from which precursors of the dendritic cells are isolated. The dendritic cell is the starter engine of the immune system. The white cells are then made into dendritic cells and they are educated to “teach” the immune system how to recognize brain cancer cells. Eligible patients will receive a series of injections of DCVax-L, to activate and then boost the immune response to the tumor cells.

Stacy D’Andre, M.D.

Samuel Ciricillo, M.D., FACS

ASPIRE-Adult Spasticity International Registry on Botox Treatment

This study will determine patterns of utilization of BOTOX for the treatment of spasticity, including but not limited to characteristics of enrolling and treating health care providers, and practices, measured by satisfaction and safety. This study will not provide or recommend any treatment.

Nicklesh Thakur, M.D.

An Open Label, Multicenter Study, Evaluating the Safety and Imaging Characteristics of 18F-AV-1451 in Cognitively Healthy Volunteers, Subjects with Mild Cognitive Impairment, and Subjects with Alzheimer’s Disease.

This is a Phase II cross-sectional and longitudinal observational study that will evaluate imaging characteristics of 18F-AV-1451 in cognitive healthy control subjects and patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD).

Stephen Falen, M.D.

A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of cannabidiol (GWP42003-P) in children and young adults with Dravet syndrome.

To assess the efficacy of GWP42003-P as an adjunctive antiepileptic treatment compared with placebo, with respect to the percentage change from baseline during the maintenance period of the study in convulsive seizure frequency for children with Dravet syndrome.

Michael Chez, MD

Susan Caffery, NP

A Multicenter, 26-Week Open- Label Proof-of-Concept Trial of Ganaxolone in Children with PCDH19 Female Pediatric Epilepsy And Other Rare Genetic Epilepsies Followed by 52-Week Open Label Treatment.

To evaluate the efficacy of open-label ganaxolone as adjunctive therapy for uncontrolled seizures in children with genetic epilepsies including female children with PCDH19 mutation.

Michael Chez, MD

Susan Caffery, NP

The Synchronous Sign This study is a single-blinded investigation of a novel neurological sign for the early detection of Lewy body/Parkinson disease

Shawn Kile, MD

William Au, MD

Nicklesh Thakur, DO


Community Events and EducationEach year, we sponsor a variety of neuroscience educational events for the community, physicians and nurses. In addition to being actively engaged in the community, our team offers continuing medical education events for primary care physicians, nurses and EMS providers.

The Sutter Neuroscience Institute also organizes case conferences for our autism, brain tumor, epilepsy, gamma knife, memory, neurology, neurovascular, and Parkinson’s and movement disorders programs. Providing opportunities to share and learn helps to keep our teams at the forefront of neuroscience best practices, which enables us to consistently provide patients with high-quality diagnosis and treatment of neurological disorders.

2015 Events

Healthcare Provider & Professional Education

• 14th Annual Nursing Symposium – Event Sponsor

• Best Practices in Neuroscience Nursing 7.5 CEU’s

• 30th Annual Neuroscience Symposium for the Primary Care Physician 8.5 AMA PRA Category 1 Credit(s)TM

• A Spine Primer for the Primary Care Physician: Assessing and Treating Patient with Spinal Pain 3.5 AMA PRA Category 1 Credit(s)TM

• Sutter Rehab Institute Stroke Symposium 6 CME’s / 7.5 CEU’s

Patient & Care Giver Education

• Back Pain 101

• Free spine community lecture – Auburn

• 13th Annual Stroke Camp – Event Sponsor

Community Walks, Fundraisers & Outreach

• 29th Annual Supported Life Conference – Event participant

• American Heart Association Sacramento Go Red for Women Luncheon – Event participant

• Celebrando Nuestra Salud 2015 – Event sponsor

• Epilepsy Foundation 5th Annual Candlelight Gala Dinner – Gold Flame sponsor

• Hot Jazz Jubilee – Event participant

• March of Dimes – Event participant

• Sutter Medical Center, Sacramento Community Day Event

• Walk MS: Solano County and Sacramento – Event Sponsor


Neuroscience Support Groups Please call Sutter Neuroscience Institute at (888) 287-2270 to learn more about attending one of our support groups.

• ALS/Lou Gehrig’s Disease Support Group

• Brain Injury Support Group

• Essential Tremor Support Group

• Greater Sacramento Brain & Aneurysm & AVM Support Group

• Parkinson’s Support Group

• Post-concussion Syndrome Support Group

• Sleep Disorders Support Group

• Stroke Support Group

• Stroke Caregivers Support Group

• Trigeminal Neuralgia Support Group

Patients may register and learn more about the classes, support groups and events by visiting our website: checksutterfirst.org/classes.

PhilanthropyGenerous Donors Make All the Difference

With philanthropic gifts, we purchase life-saving equipment, keep up with rapid changes in medical technology, offer comprehensive wellness and preventive care, and expand essential and innovative community outreach. Gifts help us extend care beyond the walls of our facilities to help people with little or no access to health care.

All gifts made to Sutter Neuroscience Institute, regardless of their size, have a significant impact on the care we provide at Sutter Health. By funding innovative equipment like the latest Gamma Knife equipment or supporting services in our Memory Clinic, our donors have a direct impact on our ability to provide personalized, high-quality care.

Find out what your gift can accomplish by contacting the Sutter Health Valley Area Philanthropy Office at (855) 421-3221 or [email protected].

Autism Nalini Chandra, M.D.

Michael Chez, M.D.

Shawn Kile, M.D.

Ashutosh Raina, M.D.

Cognition and MemoryWilliam J. Au, M.D.

Shawn Kile, M.D.

Craniofacial Samuel F. Ciricillo, M.D., FACS

Granger Wong, M.D.

Epilepsy (Adult & Pediatric)Shalesh Asaikar, M.D.

Michael Chez, M.D.

Shubhangi C. Chitnis, M.D.

Paul M. Chretien, M.D.

Samuel F. Ciricillo, M.D., FACS

Nicole Lopez-Seminario, M.D.

Vasanthi Krishna, M.D.


Ardeep Sekhon, M.D.

Eniko Nagy-Wilde, M.D.

Gamma Knife Radiosurgery/ Neuro-Oncology

NEUROSURGERY

Jessie Babbitz, M.D.


Cully A. Cobb III, M.D.

Matthew Kimball, M.D.

Rudolph Schrot, M.D.

Edie Zusman, M.D., FACS

NEURO-ONCOLOGY

Stacy D’Andre, M.D.

RADIATION ONCOLOGY

Janice K. Ryu, M.D., FACR

Jeffrey M. Suplica, M.D.

Harvey Wolkov, M.D., FACR

Movement Disorders/DBSCully A. Cobb III, M.D.

Nicklesh Thakur, D.O.

Linda Ramatowski, FNP-C

http://checksutterfirst.org/classes

mailto:[email protected]


Multiple Sclerosis William Au, M.D.

Jacqueline Chan, M.D., FAAN, Ph.D.

David Chesak, M.D.


Neurointerventional RadiologyLotfi Hacein-Bey, M.D.

Bahram Varjavand, M.D.

Neurology (Adult)Lorenzo O. Aguilar, Jr., M.D.

Kristin D. Ashley, M.D.

Richard P. Atkinson, M.D.

William J. Au, M.D.

Neerali Bernard, D.O.

Jacqueline Chan, M.D., FAAN, Ph.D.

David P. Chesak, M.D.

A. Reza Ehyai, M.D.

Asish Ghoshal, M.D.

Kanwardeep Grewal, M.D.

Bettina Harner, M.D.

William G. Hope, M.D.

Billy Hu, M.D.

Myra Q. Hu, M.D.

Shawn Kile, M.D.

Stephen F. Knox, M.D.

Vasanthi Krishna, M.D.

Christina Law, NP-C, PA-C

Jeffrey Levin, M.D.

M. Asim Mahmood, M.D.

Eniko E. Nagy-Wilde, M.D.

Anil Neelakantan, M.D.

Ardeep Sekhon, M.D.

David Seminer, M.D.


James C. Stoody, M.D.

Steven H. Suga, M.D.

Nicklesh Thakur, D.O.

Donald Van Fossan, M.D.

Jinmei Woan, M.D.

Nadine H. Yassa, M.D.

Neurology (Pediatric)Shalesh Asaikar, M.D.

Susan Caffery, FNP-C

Nalini Chandra, M.D.

Michael Chez, M.D.

Shubhangi Chitnis, M.D.

Paul Chretien, M.D.

Amer Khan, M.D.

Inna Markiv, PA-C


Neuropsychology (Adult & Pediatric)Jennifer Alford, Ph.D

Gregory Fields, Ph.D.

Kimberly E. Rose, Ph.D.

Christy Shaw, Fellow

Neurophysiology

Kanwardeep S. Grewal, M.D.

Nicole A. Lopez-Seminario, M.D.

Eniko E. Nagy-Wilde, M.D.

Ardeep K. Sekhon, M.D.

Jinmei Woan, M.D.

Neuroradiology

Letizia Antonietti, M.D.

Jonathan Breslau, M.D. F.A.C.R.

Matthew Chan, M.D.

Azad Ghassemi, M.D.

Randy Knutzon, M.D.

Jeffrey S. Kuo, M.D.

Arun Krishnan, M.D.

Govind Mukundan, M.D.

Tuan Nguyen, M.D.

Himaja Peddi, M.D.

Narasimhachari Raghavan, M.D.

David Seidenwurm, M.D., F.A.C.R.

James Steidler, M.D.

Calvin Wang, M.D.

David Winfield, M.D.

Neurosurgery (Adult)Hamid Aliabadi, M.D.

Dikran Bairamian, M.D.

Jesse Babbitz, M.D.

Ted I. Brindle, M.D.

John K. Capua, D.O.

B. Barry Chehrazi, M.D., FACS



Nguyen Do, M.D.

Rosemary A. Forster, PA-C

Andrew Fox, M.D.

Gregory M. Helbig, M.D.

Amirth Jamoona, M.D.

Matthew M. Kimball, M.D.

Thomas J. Mampalam, M.D.

Roderick G. Sanden, M.D.

Rudolph J. Schrot, M.D.

Kavian Shahi, M.D., Ph.D.

Roger W. Shortz, M.D.

Neurosurgery (Pediatric)Samuel F. Ciricillo, M.D., FACS

Rosemary A. Forster, PA-C

Neurotology/ENTKevin McKennan, M.D. FACS

Ophthalmology

Alexander Grand, M.D.

Richard Jones, M.D.

Robert Peabody, M.D.

Denise Satterfield, M.D.

Christian Serdahl, M.D.

Pain Management Natalia Balytsky, M.D.

Anthony Bellomo, M.D.

Peter Bravos, M.D.

Jackie Chan, M.D.

William J. Conrad, M.D.

Juan J. Egas Valencia, M.D.

Kayvan D. Haddadan, M.D.

Michael Hembd, M.D.

Jay A. Hendickson, M.D.

Kelly B. Hunt, M.D.

Michael L. Levin, M.D.

Navdeep Nijher, M.D.

Conor W. O’Neill, M.D.

Karen Pantazis, M.D.

Stephen Parkinson, M.D.

Juan Sarti, M.D.

Lee T. Snook, Jr., M.D.

Deepak Sreedharan, M.D.

Valery D. Tarasenko, M.D

David P, Teicheira, M.D

James A. Willia, M.D.

Min Zheng, M.D.

Sleep Disorders (Adult & Pediatric)Shawn S. Aghili, M.D.

Bradley E. Chipps, M.D.

Michael Davis, M.D.


Amer H. Khan, M.D.

Vasanthi Krishna

Drew Logue, M.D.

Jose P. Miranda, M.D.

Robert G. Monie, M.D.

Anit B. Patel, M.D.

Kayalvizhi Sambandam, M.D.

Ajitpal Sethi, M.D.

Donal Van Fossen, M.D.

Lydia M. Wytrzes, M.D.

Spine Surgery (Adult)Hamid Aliabadi, M.D.

Laura J. Anderson, M.D., FACS

Ardavan M. Aslie, M.D.

Jesse Babbitz, M.D.

Ted I. Brindle, M.D.

John K. Capua, D.O.

B. Barry Chehrazi, M.D., FACS


Morteza M. Farr, D.O.

Andrew Fox, M.D.

Mark F. Hambly, M.D.

Matthew M. Kimball, M.D.

Thomas J. Mampalam, M.D.

Christopher O. Neubuerger M.D.

Philip J. Orisek, M.D.

George Picetti, III, M.D.

Praveen Prasad, M.D.

Santi D. Rao, M.D.

Roderick G. Sanden, M.D.

David C. Schiff, M.D.

Gary A. Schneiderman, M.D.

Rudolph J. Schrot, M.D.

Kavian Shahi, M.D., Ph.D.

Tyler G. Smith, M.D.

Spine Surgery (Pediatric)George Picetti, III, M.D.

Stroke Richard P. Atkinson, M.D.

Billy Hu, M.D.

M. Asim Mahmood, M.D.


To refer a patient, call Sutter Health Transfer & Physician Referral Center at (877) 777-6680

Out of Area Referrals Sutter Specialty Network (24 Hour) (888) 834-1788

Administration PO Box 160727 Sacramento, CA 95816 Main Line (toll-free): 1-888-287-2270 Main E-mail: [email protected]

sutterneuro.org

mailto:[email protected]

http://sutterneuro.org

sni neuro 2015 annual report

Documents